Xuan Wang

Identification and mapping of worldwide sources of generic real‐world data

R. Przybysz, K. Kahler, R. Lahoz, 2019, Pharmacoepidemiology and drug safety.

Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancer

Jia Wei, Baorui Liu, Lixia Yu, 2022, Journal of Cancer Research and Clinical Oncology.

Quantifying and Interpreting Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Cancer Control for Advanced Gastroesophageal Cancer Among an Older Population.

Lee-Jen Wei, D. H. Kim, Xuan Wang, 2021, JAMA oncology.

E cacy of Silver Needle Therapy for The Treatment of Chronic Nonspeci c Low Back Pain: A Prospective, Single-Center, Randomized, Parallel- Controlled Clinical Trial

Xuan Wang, Chuansheng Liu, X. Hu, 2020 .

Adverse event profiles of adjuvant treatment with opicapone in Parkinson’s disease: A systematic review and meta-analysis

Wei Zhang, Mingming Deng, Muhan Lü, 2022, Frontiers in Pharmacology.

A Targeted Literature Review Examining Biologic Therapy Compliance and Persistence in Chronic Inflammatory Diseases to Identify the Associated Unmet Needs, Driving Factors, and Consequences

N. Maniadakis, J. Curtis, M. Schiff, 2018, Advances in Therapy.

Change in Adipokines and Gastrointestinal Hormones After Bariatric Surgery: a Meta-analysis

Cunchuan Wang, Jingge Yang, Xuan Wang, 2023, Obesity Surgery.

Efficacy and safety of first-line therapies in EGFR-mutated advanced non-small-cell lung cancer: a network meta-analysis.

H. Thom, S. Traore, K. Haeussler, 2022, Future oncology.